Comparison of inpatient insulin regimens with detemir plus aspart Versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 2, 2009, Pages 564-569

  Umpierrez, Guillermo E ^a   Hor, Tiffany ^c   Smiley, Dawn ^a   Temponi, Angel ^a   Umpierrez, Denise ^a   Ceron, Miguel ^a   Munoz, Christina ^c   Newton, Christopher ^a   Peng, Limin ^b   Baldwin, David ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 59749088828     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1441     Document Type: Article

References (39)

1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE 2002 Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982
2. Capes SE, Hunt D, Malmberg K, Gerstein HC 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
3. Estrada CA, Young JA, Nifong LW, Chitwood Jr WR 2003 Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75:1392-1399
4. Pomposelli JJ, Baxter 3rd JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR 1998 Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 22:77-81
5. Kitabchi AE, Freire AX, Umpierrez GE 2008 Evidence for strict inpatient blood glucose control: time to revise glycemic goals in hospitalized patients. Metabolism 57:116-120
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
7. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC 2001 Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426-2432
8. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR 2002 Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59:67-71
9. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsh IB 2004 Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27:553-597
10. Levetan CS, Magee MF 2000 Hospital management of diabetes. Endocrinol Metab Clin North Am 29:745-770
11. Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass ML 2006 Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital. J Hosp Med 1:145-150
12. Umpierrez GE, Maynard G 2006 Glycemic chaos (not glycemic control) still the rule for inpatient care. J Hosp Med 1:141-144
13. Queale WS, Seidler AJ, Brancati FL 1997 Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 157:545-552
14. Baldwin D, Villanueva G, McNutt R, Bhatnagar S 2005 Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 28:1008-1011
15. Umpierrez GE, Palacio A, Smiley D 2007 Sliding scale insulin use: myth or insanity? Am J Med 120:563-567
16. Owens DR, Coates PA, Luzio SD, Tinbergen JP, Kurzhals R 2000 Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 23:813-819
17. Heinemann L 2002 Variability of insulin absorption and insulin action. Diabetes Technol Ther 4:673-682
18. Inzucchi SE 2006 Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 355:1903-1911
19. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R 2007 Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30:2181-2186
20. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA 2006 Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:2739-2748
21. Finney SJ, Zekveld C, Elia A, Evans TW 2003 Glucose control and mortality in critically ill patients. JAMA 290:2041-2047
22. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL 2002 Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748-1754
23. Norhammar AM, Ryden L, Malmberg K 1999 Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 22:1827-1831
24. Montori VM, Bistrian BR, McMahon MM 2002 Hyperglycemia in acutely ill patients. JAMA 288:2167-2169
25. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC 2004 Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982-988
26. Umpierrez GE, Kitabchi AE 2004 ICU care for patients with diabetes. Curr Opin Endocrinol 11:75-81
27. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW 2007 Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care 30:367-369
28. Baldwin D, Braithwaite S, Arnold P, Selig P, Brake H, Cuny J, Cerese J 2006 The University Health System Consortium (UHC) Benchmarking Project: evaluation of hospital glycemic control at academic medical centers (AMC). Diabetes 55(Suppl 1):104
29. Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, Argueta R, Hull BP, Zimmerman RS 2007 Diabetes care in hospitalized noncritically ill patients: more evidence for clinical inertia and negative therapeutic momentum. J Hosp Med 2:203-211
30. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y 1999 Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 159:281-284
31. Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE 2007 Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med 2:234-240
32. Krinsley JS, Grover A 2007 Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 35:2262-2267
33. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P 2003 Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359-366
34. 2005 Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28:1245-1249
35. Gerich JE 2004 Insulin glargine: long-acting basal insulin analog for improved metabolic control. Curr Med Res Opin 20:31-37
36. Kiess W, Raile K, Galler A, Kapellen T 2004 Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes. Diabetes Care 27:2567-2568
37. Hermansen K, Madsbad S, Perrild H, Kristensen A, Axelsen M 2001 Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 24:296-301
38. Riddle MC, Rosenstock J, Gerich J 2003 The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080-3086
39. Michota F 2007 What are the disadvantages of the sliding scale? J Hosp Medicine 2(Suppl 1):20-22